3B Blackbio Dx Limited (BOM:532067)

3B Blackbio Dx Statistics

Total Valuation

3B Blackbio Dx has a market cap or net worth of INR 14.07 billion. The enterprise value is 13.91 billion.

Market Cap	14.07B
Enterprise Value	13.91B

Important Dates

The last earnings date was Friday, February 6, 2026.

Earnings Date	Feb 6, 2026
Ex-Dividend Date	Sep 19, 2025

Share Statistics

3B Blackbio Dx has 8.57 million shares outstanding. The number of shares has increased by 1.69% in one year.

Current Share Class	8.57M
Shares Outstanding	8.57M
Shares Change (YoY)	+1.69%
Shares Change (QoQ)	-1.03%
Owned by Insiders (%)	47.56%
Owned by Institutions (%)	3.82%
Float	2.78M

Valuation Ratios

The trailing PE ratio is 24.27.

PE Ratio	24.27
Forward PE	n/a
PS Ratio	10.91
PB Ratio	4.63
P/TBV Ratio	4.72
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	24.20
EV / Sales	10.78
EV / EBITDA	24.77
EV / EBIT	25.27
EV / FCF	n/a

Financial Position

Current Ratio	n/a
Quick Ratio	n/a
Debt / Equity	0.00
Debt / EBITDA	0.00
Debt / FCF	n/a
Interest Coverage	311.43

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	n/a
Return on Invested Capital (ROIC)	15.19%
Return on Capital Employed (ROCE)	n/a
Weighted Average Cost of Capital (WACC)	6.59%
Revenue Per Employee	15.17M
Profits Per Employee	6.76M
Employee Count	85
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

In the past 12 months, 3B Blackbio Dx has paid 167.02 million in taxes.

Income Tax	167.02M
Effective Tax Rate	22.31%

Stock Price Statistics

The stock price has decreased by -5.22% in the last 52 weeks. The beta is 0.42, so 3B Blackbio Dx's price volatility has been lower than the market average.

Beta (5Y)	0.42
52-Week Price Change	-5.22%
50-Day Moving Average	1,494.59
200-Day Moving Average	1,489.97
Relative Strength Index (RSI)	50.92
Average Volume (20 Days)	7,082

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, 3B Blackbio Dx had revenue of INR 1.29 billion and earned 574.68 million in profits. Earnings per share was 67.66.

Revenue	1.29B
Gross Profit	926.03M
Operating Income	550.30M
Pretax Income	748.62M
Net Income	574.68M
EBITDA	561.38M
EBIT	550.30M
Earnings Per Share (EPS)	67.66

Balance Sheet

The company has 227.67 million in cash and 2.62 million in debt, with a net cash position of 225.05 million or 26.27 per share.

Cash & Cash Equivalents	227.67M
Total Debt	2.62M
Net Cash	225.05M
Net Cash Per Share	26.27
Equity (Book Value)	3.04B
Book Value Per Share	355.75
Working Capital	n/a

Cash Flow

Operating Cash Flow	n/a
Capital Expenditures	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Margins

Gross margin is 71.80%, with operating and profit margins of 42.67% and 44.56%.

Gross Margin	71.80%
Operating Margin	42.67%
Pretax Margin	58.04%
Profit Margin	44.56%
EBITDA Margin	43.52%
EBIT Margin	42.67%
FCF Margin	n/a

Dividends & Yields

This stock pays an annual dividend of 4.00, which amounts to a dividend yield of 0.24%.

Dividend Per Share	4.00
Dividend Yield	0.24%
Dividend Growth (YoY)	33.33%
Years of Dividend Growth	2
Payout Ratio	n/a
Buyback Yield	-1.69%
Shareholder Yield	-1.45%
Earnings Yield	4.08%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Altman Z-Score	n/a
Piotroski F-Score	1